Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €40.37 EUR
Change Today -3.76 / -8.52%
Volume 20.0
8FM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 1:24 PM 04/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven Kafka Ph.D.

President and Chief Operating Officer, Foundation Medicine, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

45$1,127,369
As of Fiscal Year 2013

Background*

Dr. Steven J. Kafka, also known as Steve, Ph.D. serves as the Chief Operating Officer of Foundation Medicine, Inc. and has been its President since March 23, 2015. Dr. Kafka has broad responsibility for business development and operational functions. He served as the Chief Operating Officer of Aileron Therapeutics, Inc since June 2011 until October 2012. He served as the Chief Financial Officer at Aileron Therapeutics Inc., since October 2009 until October 2012. He led ...

Read Full Background

Corporate Headquarters*

150 Second Street
Cambridge, Massachusetts 02141

United States

Phone: 617-418-2200
Fax: 617-418-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Harvard University
BA
Stanford University

Other Affiliations*

Annual Compensation*

Salary$336,825
Total Annual Compensation$336,825

Stock Options*

Exercisable Options10,156
Exercisable Options Value$176,540
Unexercisable Options202,344
Unexercisable Options Value$3,816,210
Total Value of Options$3,992,750
Total Number of Options212,500

Total Compensation*

Total Annual Cash Compensation$469,825
Total Short Term Compensation$336,825
Total Calculated Compensation$1,127,369
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8FM:GR €40.37 EUR -3.76

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$400.0K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$557.0K
Kimberly J. Popovits Chairman of the Board, Chief Executive Officer, President and Member of Non-Management Stock Option Committee
Genomic Health Inc.
$600.0K
Panna Sharma Chief Executive Officer, President and Director
Cancer Genetics, Inc.
$649.0K
Bonnie H. Anderson Co-Founder, Chief Executive Officer, President, Director and Member of Non-Management Equity Award Committee
Veracyte, Inc.
$425.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FOUNDATION MEDICINE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.